Vascular and stroma normalization can be achieved by combining anti-VEGF treatment with stroma normalizing agents (e.g. Losartan (42) and Ketotifen(43)) to pre-condition the tumor microenvironment prior to therapy. Here, VEGFA is linked to neoplasm.